Skip to main content
Figure 2 | Genetic Vaccines and Therapy

Figure 2

From: Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage

Figure 2

Immunomodulatory activity of pVAXhsp65 in young mice. Young mice received 3 pVAXhsp65 doses (50 μg/im route) delivered at 5, 12 and 19-day-old. Production of IFN-γ (a); IL-4 (b) and IL-5 (c) by splenic cells stimulated with ConA and serum levels of specific anti-hsp65 antibodies (d) were determined two weeks later. Results represent the geometric mean ± SEM of 4 to 8 individually tested animals per group. *p < 0.05 in comparison to vector group.

Back to article page